Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey L Brower

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
American Journal of Obstetrics and Gynecology|February 18, 2014
A chemoresponse assay for prediction of platinum resistance in primary ovarian cancerThomas C Krivak, Shashikant Lele, Scott Richard, et al.
Gynecologic Oncology|June 4, 2015
Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysisRebecca Previs, Charles A Leath, Robert L Coleman, et al.
Gynecologic Oncology|December 3, 2014
A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancerVictoria Plamadeala, Joseph L Kelley, John K Chan, et al.
American Journal of Obstetrics and Gynecology|April 27, 2010
Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitroSarah N Cross, Emiliano Cocco, Stefania Bellone, et al.
Plos One|July 21, 2012
Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell linesKui Shen, Shara D Rice, David A Gingrich, et al.
BMC Medical Genomics|November 20, 2012
Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trialKui Shen, Yuan Qi, Nan Song, et al.
Gynecologic Oncology|August 20, 2013
A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancerThomas Rutherford, James Orr, Edward Grendys, et al.
The Journal of Molecular Diagnostics : JMD|May 12, 2015
Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized TissueShuguang Huang, Nicholas J Reitze, Amy L Ewing, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Obstetrics and Gynecology|February 18, 2014
A chemoresponse assay for prediction of platinum resistance in primary ovarian cancerThomas C Krivak, Shashikant Lele, Scott Richard, et al.
Gynecologic Oncology|June 4, 2015
Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysisRebecca Previs, Charles A Leath, Robert L Coleman, et al.
Gynecologic Oncology|December 3, 2014
A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancerVictoria Plamadeala, Joseph L Kelley, John K Chan, et al.
American Journal of Obstetrics and Gynecology|April 27, 2010
Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitroSarah N Cross, Emiliano Cocco, Stefania Bellone, et al.
Plos One|July 21, 2012
Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell linesKui Shen, Shara D Rice, David A Gingrich, et al.
BMC Medical Genomics|November 20, 2012
Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trialKui Shen, Yuan Qi, Nan Song, et al.
Gynecologic Oncology|August 20, 2013
A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancerThomas Rutherford, James Orr, Edward Grendys, et al.
The Journal of Molecular Diagnostics : JMD|May 12, 2015
Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized TissueShuguang Huang, Nicholas J Reitze, Amy L Ewing, et al.
Pageof 2